Share Price and Basic Stock Data
Last Updated: October 8, 2025, 8:55 pm
| PEG Ratio | 8.69 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Mohini Health & Hygiene Ltd, operating in the Medical Equipment & Accessories industry, has a market price of ₹50.1 with a Market Cap of ₹91.4 Cr. The company’s performance can be assessed through its quarterly and annual sales trends, with a Net Profit of ₹6 Cr. Operating Profit Margin (OPM) stands at 3%, indicating a moderate level of profitability. It is crucial to closely monitor sales and expenses to ensure sustained growth and efficiency in operations.
Profitability and Efficiency Metrics
With a Price-to-Earnings (P/E) ratio of 8.84, Return on Equity (ROE) at 10.0%, and Return on Capital Employed (ROCE) at 14.1%, Mohini Health & Hygiene Ltd showcases decent profitability. The Interest Coverage Ratio (ICR) of 5.16x reflects a healthy ability to meet interest obligations. However, the Cash Conversion Cycle (CCC) of 127 days suggests room for improvement in managing working capital efficiently.
Balance Sheet Strength and Financial Ratios
The company holds Reserves worth ₹87 Cr and Borrowings of ₹35 Cr, indicating a stable financial position. The Price-to-Book Value (P/BV) ratio of 0.95x suggests the stock may be undervalued compared to its book value. Monitoring Debt-Equity ratios and liquidity metrics is essential to assess the company’s financial health and growth prospects accurately.
Shareholding Pattern and Investor Confidence
Promoters hold a significant stake at 64.02%, while FIIs and DIIs currently show no holdings, with the public holding at 34.96%. Changes in the shareholding pattern can reflect shifts in investor confidence and impact the company’s valuation and market sentiment. Analyzing these trends over time provides insights into the company’s perceived stability and growth potential.
Outlook, Risks, and Final Insight
Looking ahead, Mohini Health & Hygiene Ltd can capitalize on growth drivers such as expanding product lines or entering new markets to enhance revenue streams. However, risks such as regulatory changes or intense competition could pose challenges. Strengthening operational efficiency and maintaining investor trust will be key to navigating future uncertainties. In conclusion, the company’s financial indicators suggest a foundation for growth, but strategic planning and risk management are essential for long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Mohini Health & Hygiene Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Constronics Infra Ltd | 82.1 Cr. | 65.5 | 158/46.0 | 19.5 | 30.9 | 0.00 % | 19.7 % | 15.8 % | 10.0 |
| Centenial Surgical Suture Ltd | 39.4 Cr. | 108 | 189/82.2 | 84.3 | 0.00 % | 3.94 % | 4.64 % | 10.0 | |
| Adeshwar Meditex Ltd | 23.4 Cr. | 16.2 | 26.5/15.0 | 11.8 | 25.6 | 0.00 % | 8.27 % | 5.51 % | 10.0 |
| Poly Medicure Ltd | 19,258 Cr. | 1,902 | 3,358/1,821 | 53.9 | 273 | 0.18 % | 20.1 % | 15.8 % | 5.00 |
| Mohini Health & Hygiene Ltd | 91.1 Cr. | 50.0 | 86.9/46.0 | 8.82 | 57.8 | 0.00 % | 14.1 % | 10.0 % | 10.0 |
| Industry Average | 19,258.00 Cr | 428.34 | 23.51 | 94.32 | 0.04% | 13.22% | 10.35% | 9.00 |
Quarterly Result
| Metric | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 59 | 62 | 66 | 72 | 63 | 46 | 82 | 99 | 93 | 101 | 98 | 91 | 76 |
| Expenses | 48 | 54 | 63 | 60 | 59 | 40 | 78 | 94 | 85 | 94 | 92 | 82 | 74 |
| Operating Profit | 10 | 8 | 3 | 12 | 5 | 6 | 4 | 5 | 7 | 8 | 6 | 9 | 3 |
| OPM % | 18% | 13% | 4% | 17% | 7% | 13% | 4% | 5% | 8% | 8% | 6% | 10% | 3% |
| Other Income | 0 | 0 | 6 | 0 | 0 | 1 | 6 | 6 | 0 | 4 | 4 | 1 | 3 |
| Interest | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 1 | 2 |
| Depreciation | 3 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Profit before tax | 5 | 4 | 4 | 7 | 0 | 2 | 6 | 8 | 3 | 7 | 6 | 7 | 2 |
| Tax % | 0% | 5% | 31% | 0% | 3,780% | 25% | 31% | 32% | 46% | 28% | 10% | 30% | 35% |
| Net Profit | 5 | 4 | 3 | 7 | -2 | 2 | 4 | 5 | 2 | 5 | 6 | 5 | 1 |
| EPS in Rs | 2.74 | 1.99 | 1.48 | 4.10 | -1.01 | 0.90 | 2.09 | 2.81 | 0.91 | 2.83 | 3.07 | 2.64 | 0.61 |
Last Updated: May 31, 2025, 8:24 am
Below is a detailed analysis of the quarterly data for Mohini Health & Hygiene Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 76.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Sep 2024) to 76.00 Cr., marking a decrease of 15.00 Cr..
- For Expenses, as of Mar 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 82.00 Cr. (Sep 2024) to 74.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2024) to 3.00 Cr., marking a decrease of 6.00 Cr..
- For OPM %, as of Mar 2025, the value is 3.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Sep 2024) to 3.00%, marking a decrease of 7.00%.
- For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Sep 2024) to 2.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Mar 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 30.00% (Sep 2024) to 35.00%, marking an increase of 5.00%.
- For Net Profit, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Sep 2024) to 1.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.61. The value appears to be declining and may need further review. It has decreased from 2.64 (Sep 2024) to 0.61, marking a decrease of 2.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 4:45 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49 | 91 | 122 | 137 | 148 | 127 | 128 | 135 | 127 | 192 | 200 | 168 |
| Expenses | 47 | 86 | 112 | 127 | 130 | 107 | 117 | 118 | 118 | 179 | 186 | 156 |
| Operating Profit | 2 | 5 | 10 | 10 | 17 | 20 | 11 | 17 | 9 | 13 | 14 | 12 |
| OPM % | 4% | 5% | 8% | 7% | 12% | 16% | 8% | 12% | 7% | 7% | 7% | 7% |
| Other Income | 0 | 0 | 1 | 3 | 2 | 1 | 6 | 0 | 7 | 6 | 8 | 5 |
| Interest | 1 | 1 | 4 | 3 | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 |
| Depreciation | 0 | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 |
| Profit before tax | 1 | 3 | 4 | 8 | 7 | 10 | 8 | 8 | 8 | 11 | 13 | 9 |
| Tax % | 32% | 24% | 10% | 27% | 30% | 26% | 18% | 25% | 29% | 36% | 20% | 31% |
| Net Profit | 1 | 2 | 4 | 6 | 5 | 8 | 6 | 6 | 5 | 7 | 11 | 6 |
| EPS in Rs | 2.88 | 7.62 | 15.03 | 18.83 | 2.81 | 4.21 | 3.46 | 3.09 | 2.99 | 3.72 | 5.89 | 3.25 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 8% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 100.00% | 50.00% | -16.67% | 60.00% | -25.00% | 0.00% | -16.67% | 40.00% | 57.14% | -45.45% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | -50.00% | -66.67% | 76.67% | -85.00% | 25.00% | -16.67% | 56.67% | 17.14% | -102.60% |
Mohini Health & Hygiene Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: June 16, 2025, 11:41 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves | 10 | 12 | 16 | 21 | 40 | 48 | 54 | 59 | 65 | 71 | 82 | 87 |
| Borrowings | 23 | 52 | 58 | 65 | 56 | 51 | 42 | 43 | 44 | 28 | 23 | 35 |
| Other Liabilities | 5 | 18 | 11 | 18 | 20 | 16 | 19 | 22 | 22 | 21 | 17 | 28 |
| Total Liabilities | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 |
| Fixed Assets | 6 | 44 | 42 | 41 | 64 | 63 | 60 | 64 | 50 | 49 | 40 | 37 |
| CWIP | 18 | 0 | 1 | 21 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Other Assets | 17 | 40 | 44 | 44 | 70 | 70 | 72 | 79 | 98 | 89 | 98 | 127 |
| Total Assets | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 |
Below is a detailed analysis of the balance sheet data for Mohini Health & Hygiene Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
- For Reserves, as of Mar 2025, the value is 87.00 Cr.. The value appears strong and on an upward trend. It has increased from 82.00 Cr. (Mar 2024) to 87.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Mar 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 23.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 12.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 28.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 11.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 168.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 140.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 28.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2024) to 37.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
- For Other Assets, as of Mar 2025, the value is 127.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2024) to 127.00 Cr., marking an increase of 29.00 Cr..
- For Total Assets, as of Mar 2025, the value is 168.00 Cr.. The value appears strong and on an upward trend. It has increased from 140.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 28.00 Cr..
Notably, the Reserves (87.00 Cr.) exceed the Borrowings (35.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -21.00 | -47.00 | -48.00 | -55.00 | -39.00 | -31.00 | -31.00 | -26.00 | -35.00 | -15.00 | -9.00 | -23.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 133 | 49 | 64 | 89 | 82 | 65 | 60 | 112 | 67 | 72 | 39 |
| Inventory Days | 52 | 15 | 58 | 37 | 44 | 79 | 94 | 126 | 106 | 65 | 55 | 117 |
| Days Payable | 13 | 44 | 14 | 13 | 15 | 16 | 28 | 25 | 18 | 16 | 10 | 29 |
| Cash Conversion Cycle | 65 | 105 | 93 | 88 | 117 | 145 | 131 | 161 | 200 | 116 | 117 | 127 |
| Working Capital Days | 72 | 43 | 24 | 1 | 47 | 66 | 70 | 66 | 110 | 96 | 116 | 120 |
| ROCE % | 8% | 6% | 12% | 13% | 14% | 14% | 10% | 10% | 9% | 12% | 14% | 14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.86 | 3.72 | 3.71 | 3.25 | 3.58 |
| Diluted EPS (Rs.) | 5.86 | 3.72 | 3.71 | 3.25 | 3.58 |
| Cash EPS (Rs.) | 8.22 | 6.07 | 6.78 | 6.39 | 6.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 55.05 | 49.19 | 46.03 | 42.70 | 39.57 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 55.05 | 49.19 | 46.03 | 42.70 | 39.57 |
| Revenue From Operations / Share (Rs.) | 109.46 | 105.29 | 77.94 | 75.39 | 71.11 |
| PBDIT / Share (Rs.) | 12.00 | 10.44 | 9.59 | 9.90 | 9.36 |
| PBIT / Share (Rs.) | 9.64 | 8.10 | 6.69 | 6.90 | 6.58 |
| PBT / Share (Rs.) | 7.31 | 5.82 | 4.77 | 4.54 | 4.24 |
| Net Profit / Share (Rs.) | 5.86 | 3.72 | 3.89 | 3.39 | 3.58 |
| NP After MI And SOA / Share (Rs.) | 5.86 | 3.72 | 3.71 | 3.25 | 3.58 |
| PBDIT Margin (%) | 10.96 | 9.91 | 12.30 | 13.13 | 13.16 |
| PBIT Margin (%) | 8.80 | 7.69 | 8.58 | 9.14 | 9.24 |
| PBT Margin (%) | 6.68 | 5.53 | 6.12 | 6.02 | 5.95 |
| Net Profit Margin (%) | 5.35 | 3.53 | 4.98 | 4.49 | 5.03 |
| NP After MI And SOA Margin (%) | 5.35 | 3.53 | 4.76 | 4.30 | 5.03 |
| Return on Networth / Equity (%) | 10.64 | 7.56 | 8.12 | 7.63 | 9.04 |
| Return on Capital Employeed (%) | 15.83 | 14.35 | 13.05 | 13.42 | 13.51 |
| Return On Assets (%) | 7.65 | 4.90 | 4.30 | 4.03 | 4.87 |
| Long Term Debt / Equity (X) | 0.05 | 0.09 | 0.06 | 0.15 | 0.18 |
| Total Debt / Equity (X) | 0.22 | 0.31 | 0.52 | 0.46 | 0.48 |
| Asset Turnover Ratio (%) | 1.44 | 1.30 | 0.93 | 0.98 | 0.97 |
| Current Ratio (X) | 3.19 | 2.43 | 1.57 | 1.47 | 1.54 |
| Quick Ratio (X) | 2.41 | 1.73 | 1.15 | 0.89 | 1.01 |
| Inventory Turnover Ratio (X) | 6.25 | 5.42 | 3.42 | 3.11 | 4.32 |
| Interest Coverage Ratio (X) | 5.16 | 4.59 | 4.99 | 4.21 | 4.00 |
| Interest Coverage Ratio (Post Tax) (X) | 3.52 | 2.64 | 3.02 | 2.44 | 2.53 |
| Enterprise Value (Cr.) | 113.80 | 119.96 | 93.74 | 79.60 | 54.34 |
| EV / Net Operating Revenue (X) | 0.57 | 0.62 | 0.65 | 0.57 | 0.41 |
| EV / EBITDA (X) | 5.20 | 6.30 | 5.36 | 4.41 | 3.18 |
| MarketCap / Net Operating Revenue (X) | 0.48 | 0.48 | 0.35 | 0.32 | 0.16 |
| Price / BV (X) | 0.95 | 1.03 | 0.60 | 0.56 | 0.28 |
| Price / Net Operating Revenue (X) | 0.48 | 0.48 | 0.35 | 0.32 | 0.16 |
| EarningsYield | 0.11 | 0.07 | 0.13 | 0.13 | 0.31 |
After reviewing the key financial ratios for Mohini Health & Hygiene Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.86, marking an increase of 2.14.
- For Diluted EPS (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.86, marking an increase of 2.14.
- For Cash EPS (Rs.), as of Mar 24, the value is 8.22. This value is within the healthy range. It has increased from 6.07 (Mar 23) to 8.22, marking an increase of 2.15.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 55.05. It has increased from 49.19 (Mar 23) to 55.05, marking an increase of 5.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 55.05. It has increased from 49.19 (Mar 23) to 55.05, marking an increase of 5.86.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 109.46. It has increased from 105.29 (Mar 23) to 109.46, marking an increase of 4.17.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 12.00. This value is within the healthy range. It has increased from 10.44 (Mar 23) to 12.00, marking an increase of 1.56.
- For PBIT / Share (Rs.), as of Mar 24, the value is 9.64. This value is within the healthy range. It has increased from 8.10 (Mar 23) to 9.64, marking an increase of 1.54.
- For PBT / Share (Rs.), as of Mar 24, the value is 7.31. This value is within the healthy range. It has increased from 5.82 (Mar 23) to 7.31, marking an increase of 1.49.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.86, marking an increase of 2.14.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 5.86. This value is within the healthy range. It has increased from 3.72 (Mar 23) to 5.86, marking an increase of 2.14.
- For PBDIT Margin (%), as of Mar 24, the value is 10.96. This value is within the healthy range. It has increased from 9.91 (Mar 23) to 10.96, marking an increase of 1.05.
- For PBIT Margin (%), as of Mar 24, the value is 8.80. This value is below the healthy minimum of 10. It has increased from 7.69 (Mar 23) to 8.80, marking an increase of 1.11.
- For PBT Margin (%), as of Mar 24, the value is 6.68. This value is below the healthy minimum of 10. It has increased from 5.53 (Mar 23) to 6.68, marking an increase of 1.15.
- For Net Profit Margin (%), as of Mar 24, the value is 5.35. This value is within the healthy range. It has increased from 3.53 (Mar 23) to 5.35, marking an increase of 1.82.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.35. This value is below the healthy minimum of 8. It has increased from 3.53 (Mar 23) to 5.35, marking an increase of 1.82.
- For Return on Networth / Equity (%), as of Mar 24, the value is 10.64. This value is below the healthy minimum of 15. It has increased from 7.56 (Mar 23) to 10.64, marking an increase of 3.08.
- For Return on Capital Employeed (%), as of Mar 24, the value is 15.83. This value is within the healthy range. It has increased from 14.35 (Mar 23) to 15.83, marking an increase of 1.48.
- For Return On Assets (%), as of Mar 24, the value is 7.65. This value is within the healthy range. It has increased from 4.90 (Mar 23) to 7.65, marking an increase of 2.75.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.05, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has decreased from 0.31 (Mar 23) to 0.22, marking a decrease of 0.09.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.44. It has increased from 1.30 (Mar 23) to 1.44, marking an increase of 0.14.
- For Current Ratio (X), as of Mar 24, the value is 3.19. This value exceeds the healthy maximum of 3. It has increased from 2.43 (Mar 23) to 3.19, marking an increase of 0.76.
- For Quick Ratio (X), as of Mar 24, the value is 2.41. This value exceeds the healthy maximum of 2. It has increased from 1.73 (Mar 23) to 2.41, marking an increase of 0.68.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.25. This value is within the healthy range. It has increased from 5.42 (Mar 23) to 6.25, marking an increase of 0.83.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 5.16. This value is within the healthy range. It has increased from 4.59 (Mar 23) to 5.16, marking an increase of 0.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.52. This value is within the healthy range. It has increased from 2.64 (Mar 23) to 3.52, marking an increase of 0.88.
- For Enterprise Value (Cr.), as of Mar 24, the value is 113.80. It has decreased from 119.96 (Mar 23) to 113.80, marking a decrease of 6.16.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.62 (Mar 23) to 0.57, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 24, the value is 5.20. This value is within the healthy range. It has decreased from 6.30 (Mar 23) to 5.20, marking a decrease of 1.10.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.48. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.48.
- For Price / BV (X), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 1. It has decreased from 1.03 (Mar 23) to 0.95, marking a decrease of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.48. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 23) which recorded 0.48.
- For EarningsYield, as of Mar 24, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 23) to 0.11, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mohini Health & Hygiene Ltd:
- Net Profit Margin: 5.35%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.83% (Industry Average ROCE: 13.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.64% (Industry Average ROE: 10.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.52
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.41
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.82 (Industry average Stock P/E: 23.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.35%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Medical Equipment & Accessories | Plot No 109, Sector 3, Dhar Madhya Pradesh 454774 | cs@mohinihealthandhygiene.com, http://www.mohinihealthandhygiene.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Avnish Bansal | Managing Director |
| Mr. Viral Patel | Executive Director |
| Mr. Sarvapriya Bansal | Whole Time Director |
| Mrs. Parul Agarwal | Whole Time Director |
| Mr. Mukesh Vyas | Ind. Non-Executive Director |
| Mr. Chandrashekhar Bobra | Ind. Non-Executive Director |
| Mr. Mukul Jain | Ind. Non-Executive Director |
| Mr. Mahesh Fogla | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mohini Health & Hygiene Ltd?
Mohini Health & Hygiene Ltd's intrinsic value (as of 10 October 2025) is 41.60 which is 16.80% lower the current market price of 50.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹91.1 Cr. market cap, FY2025-2026 high/low of 86.9/46.0, reserves of ₹87 Cr, and liabilities of 168 Cr.
What is the Market Cap of Mohini Health & Hygiene Ltd?
The Market Cap of Mohini Health & Hygiene Ltd is 91.1 Cr..
What is the current Stock Price of Mohini Health & Hygiene Ltd as on 10 October 2025?
The current stock price of Mohini Health & Hygiene Ltd as on 10 October 2025 is 50.0.
What is the High / Low of Mohini Health & Hygiene Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mohini Health & Hygiene Ltd stocks is 86.9/46.0.
What is the Stock P/E of Mohini Health & Hygiene Ltd?
The Stock P/E of Mohini Health & Hygiene Ltd is 8.82.
What is the Book Value of Mohini Health & Hygiene Ltd?
The Book Value of Mohini Health & Hygiene Ltd is 57.8.
What is the Dividend Yield of Mohini Health & Hygiene Ltd?
The Dividend Yield of Mohini Health & Hygiene Ltd is 0.00 %.
What is the ROCE of Mohini Health & Hygiene Ltd?
The ROCE of Mohini Health & Hygiene Ltd is 14.1 %.
What is the ROE of Mohini Health & Hygiene Ltd?
The ROE of Mohini Health & Hygiene Ltd is 10.0 %.
What is the Face Value of Mohini Health & Hygiene Ltd?
The Face Value of Mohini Health & Hygiene Ltd is 10.0.